139 related articles for article (PubMed ID: 29430288)
1. Synthesis and Biological Evaluations of Ring Substituted Tetrahydroisoquinolines (THIQs) as Anti-Breast Cancer Agents.
Eyunni SV; Gangapuram M; Mochona B; Mateeva N; Redda KK
J Cancer Sci Ther; 2017; 9(7):528-540. PubMed ID: 29430288
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Pharmacological Evolution of Tetrahydroisoquinolines as Anti Breast Cancer Agents.
Gangapuram M; Eyunni S; Redda KK
J Cancer Sci Ther; 2014 Apr; 6():161-169. PubMed ID: 25525496
[TBL] [Abstract][Full Text] [Related]
3. In-vitro Antiproliferative Activity of New Tetrahydroisoquinolines (THIQs) on Ishikawa Cells and their 3D Pharmacophore Models.
Eyunni SK; Gangapuram M; Redda KK
Lett Drug Des Discov; 2014; 11(4):428-436. PubMed ID: 25506297
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of 3-N-substituted estrogen derivatives as breast cancer agents.
Wan Z; Musa MA; Joseph P; Cooperwood JS
Mini Rev Med Chem; 2013 Jul; 13(9):1381-8. PubMed ID: 22876946
[TBL] [Abstract][Full Text] [Related]
5. Substituted Tetrahydroisoquinolines as Microtubule-destabilizing Agents in Triple Negative Human Breast Cancer Cells.
Gangapuram M; Jean R; Mazzio E; Badisa R; Eyunni S; Goodman CB; Redda KK; Soliman KF
Anticancer Res; 2016 Oct; 36(10):5043-5052. PubMed ID: 27798863
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Docking Studies of Flavokawain B Type Chalcones and Their Cytotoxic Effects on MCF-7 and MDA-MB-231 Cell Lines.
Abu Bakar A; Akhtar MN; Mohd Ali N; Yeap SK; Quah CK; Loh WS; Alitheen NB; Zareen S; Ul-Haq Z; Shah SAA
Molecules; 2018 Mar; 23(3):. PubMed ID: 29518053
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Biological Evaluation of 2-(2-Bromo-3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole Derivatives as Possible Anti-Breast Cancer Agents.
Ananth AH; Manikandan N; Rajan RK; Elancheran R; Lakshmithendral K; Ramanathan M; Bhattacharjee A; Kabilan S
Chem Biodivers; 2020 Feb; 17(2):e1900659. PubMed ID: 31995280
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure-activity relationships and antagonistic effects in human MCF-7 breast cancer cells of flexible estrogen receptor modulators.
Lloyd DG; Smith HM; O'Sullivan T; Zisterer DM; Meegan MJ
Med Chem; 2005 Jul; 1(4):335-53. PubMed ID: 16789891
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Evaluation of Novel N-Substituted-[Benzoylamino]-5-Ethyl-1,2,3,6-Tetrahydropyridines as Potential Anti-Cancer Agents.
Henderson ED; Gangapuram M; Eyunni SKV; Redda KK; Wilson-Ardley T
Madridge J Pharm Res; 2019; 3(1):52-59. PubMed ID: 31858077
[TBL] [Abstract][Full Text] [Related]
10. Antiestrogenically active 2-benzyl-1,1-diarylbut-2-enes: synthesis, structure-activity relationships and molecular modeling study for flexible estrogen receptor antagonists.
Lloyd DG; Smith HM; O'Sullivan T; Knox AS; Zisterer DM; Meegan MJ
Med Chem; 2006 Mar; 2(2):147-68. PubMed ID: 16787364
[TBL] [Abstract][Full Text] [Related]
11. Cellular effect of styrene substituted biscoumarin caused cellular apoptosis and cell cycle arrest in human breast cancer cells.
Perumalsamy H; Sankarapandian K; Kandaswamy N; Balusamy SR; Periyathambi D; Raveendiran N
Int J Biochem Cell Biol; 2017 Nov; 92():104-114. PubMed ID: 28958615
[TBL] [Abstract][Full Text] [Related]
12. Flexible estrogen receptor modulators: synthesis, biochemistry and molecular modeling studies for 3-benzyl-4,6-diarylhex-3-ene and 3,4,6-triarylhex-3-ene derivatives.
Smith HM; Knox AJ; Zisterer DM; Lloyd DG; Meegan MJ
Med Chem; 2007 Mar; 3(2):135-55. PubMed ID: 17348852
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 2,2-dimethyl-chroman-based stereochemically flexible and constrained anti-breast cancer agents.
Nainawat KS; Gupta K; Gupta N; Singh R; Mishra D; Nirwan A; Verma M; Singh A; Vasudev PG; Khan F; Mishra DP; Gupta A
Bioorg Med Chem Lett; 2024 Aug; 108():129789. PubMed ID: 38729318
[TBL] [Abstract][Full Text] [Related]
14.
Farghadani R; Seifaddinipour M; Rajarajeswaran J; Abdulla MA; Mohd Hashim NB; Khaing SL; Salehen NB
PeerJ; 2019; 7():e7686. PubMed ID: 31608167
[TBL] [Abstract][Full Text] [Related]
15. Novel Selective Estrogen Receptor Ligand Conjugates Incorporating Endoxifen-Combretastatin and Cyclofenil-Combretastatin Hybrid Scaffolds: Synthesis and Biochemical Evaluation.
Kelly PM; Keely NO; Bright SA; Yassin B; Ana G; Fayne D; Zisterer DM; Meegan MJ
Molecules; 2017 Aug; 22(9):. PubMed ID: 28858267
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antitubulin, and antiproliferative SAR of C3/C1-substituted tetrahydroisoquinolines.
Dohle W; Leese MP; Jourdan FL; Major MR; Bai R; Hamel E; Ferrandis E; Kasprzyk PG; Fiore A; Newman SP; Purohit A; Potter BV
ChemMedChem; 2014 Feb; 9(2):350-70. PubMed ID: 24436228
[TBL] [Abstract][Full Text] [Related]
17. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Biological Investigation and Docking Study of Novel Chromen Derivatives as Anti-Cancer Agents.
Dube PN; Sakle NS; Dhawale SA; More SA; Mokale SN
Anticancer Agents Med Chem; 2019; 19(9):1150-1160. PubMed ID: 30848213
[TBL] [Abstract][Full Text] [Related]
19. Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer.
Tantivejkul K; Vucenik I; Eiseman J; Shamsuddin AM
Breast Cancer Res Treat; 2003 Jun; 79(3):301-12. PubMed ID: 12846414
[TBL] [Abstract][Full Text] [Related]
20. Development of constrained tamoxifen mimics and their antiproliferative properties against breast cancer cells.
Archana S; Geesala R; Rao NB; Satpati S; Puroshottam G; Panasa A; Dixit A; Das A; Srivastava AK
Bioorg Med Chem Lett; 2015 Feb; 25(3):680-4. PubMed ID: 25529734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]